助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[105]条 当前为第1条到20条[由于搜索限制,当前仅支持显示前5页数据]
 

相关语句
toxin type
The development of Guillain-Barré syndrome is reported in a patient, who had previously received botulinum toxin type A injections into both orbicularis oculi muscles to treat idiopathic blepharospasm.
      
Sixty patients with idiopathic cervical dystonia were treated a total of 240 times with botulinum toxin type A (BTA).
      
Efficacy and safety of a standardised 500 unit dose of Dysport? (Clostridium botulinum toxin type A haemaglutinin complex) in a
      
Results from a dose-ranging study in a selected group of de novo patients with rotational cervical dystonia (CD) suggest that 500 units of Dysport (Clostridium botulinum toxin type A haemaglutinin complex) is the optimal starting dose.
      
We recently reported a unique patient with Parkinson's disease (PD) who had significant alleviation of FOG shortly after she was injected with botulinum toxin type A (BTX-A) for foot dystonia (Giladi et al.
      
Intramuscular injections of botulinum toxin type A (BTX-A) have increasingly been used to reduce spasticity in specific muscle groups in children with cerebral palsy.
      
A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the origina
      
In 1997, the US FDA approved a new bulk toxin source (now referred to as current) for the manufacture of botulinum toxin type A (BTX-A).
      
Botulinum toxin type B for treatment of axillar hyperhidrosis
      
Recently, botulinum toxin type B (BT-B) became commercially available for treatment of cervical dystonia.
      
Botulinum toxin type B de novo therapy of cervical dystonia
      
Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis
      
Subcutaneous botulinum toxin type A inhibits regional sweating: an individual observation
      
The role of gustatory flushing in Frey's syndrome and its treatment with botulinum toxin type A
      
A retrospective review of Botulinum toxin type A compared with standard therapy in the treatment of lumbar myofascial back pain
      
There was also a significant reduction from the pre-treatment baseline in visual analogue scale scores for pain following Botulinum toxin type A injections (p = 0.002) but no significant difference for the anesthetic/steroid combination (p = 0.134).
      
In conclusion, Botulinum toxin type A therapy resulted in a significantly greater amount of time spent with significant pain reduction compared with standard anesthetic/steroids.
      
Th options are 1) supportive/social treatment, 2) physical therapies, 3) oral and intrathecal pharmacotherapy, 4) injection (botulinum toxin type A [BTX-A]) therapy, and 5) surgical therapy.
      
The use of botulinum toxin type A in headache treatment
      
Comparative trial of botulinum toxin type A and methylprednisolone for the treatment of tension-type headache
      
 

首页上一页12345下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社